Association of biomarkers with health-related quality of life and history of stressors in myalgic encephalomyelitis/chronic fatigue syndrome patients

ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56dimCD16+ and CD56brightCD16dim/− natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients

(2016) Teilah Kathryn Huth et al.   Journal of Translational Medicine

CD26: A Prognostic Marker of Acute Lymphoblastic Leukemia in Children in the Post Remission Induction Phase

(2015) Atheer Awad Mehde et al.   Asian Pacific Journal of Cancer Prevention

Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients

(2015) Sharni Lee Hardcastle et al.   Journal of Translational Medicine

Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

(2013) Michael Maes et al.   MEDICAL SCIENCE MONITOR

Mitochondrial dysfunctions in Myalgic Encephalomyelitis / chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways

(2013) Gerwyn Morris et al.   METABOLIC BRAIN DISEASE

Cognitive functioning in people with chronic fatigue syndrome: A comparison between subjective and objective measures.

(2013) Susan J. Cockshell et al.   NEUROPSYCHOLOGY

DPP4 Deficiency Exerts Protective Effect against H2O2 Induced Oxidative Stress in Isolated Cardiomyocytes

(2013) Hui-Chun Ku et al.   PLoS One

Neuropsychological Impairment in Female Patients with Chronic Fatigue Syndrome: A Preliminary Study

(2013) Pilar Santamarina-Perez et al.   Applied Neuropsychology-Adult

High cell surface CD26-associated activities and low plasma adenosine concentration in fibromyalgia

(2012) Régis Guieu et al.   ANNALS OF THE RHEUMATIC DISEASES

Immunophenotyping in post-giardiasis functional gastrointestinal disease and chronic fatigue syndrome

(2012) Kurt Hanevik et al.   BMC INFECTIOUS DISEASES

Lymphocytic enzymes and lipid peroxidation in patients with metabolic syndrome

(2012) Karine S. De Bona et al.   CLINICAL BIOCHEMISTRY

Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis

(2012) Ekua W Brenu et al.   Journal of Translational Medicine

Dipeptidyl peptidase 4 as a therapeutic target in ischemia/reperfusion injury

(2012) Veerle Matheeussen et al.   PHARMACOLOGY & THERAPEUTICS

Plasma neuropeptide Y: a biomarker for symptom severity in chronic fatigue syndrome

(2011) Mary A Fletcher et al.   Behavioral and Brain Functions

Chronic fatigue syndrome: acute infection and history of physical activity affect resting levels and response to exercise of plasma oxidant/antioxidant status and heat shock proteins

(2011) Y. Jammes et al.   JOURNAL OF INTERNAL MEDICINE

Quality and acceptability of patient-reported outcome measures used in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review

(2011) Kirstie L. Haywood et al.   QUALITY OF LIFE RESEARCH

Effects of H2O2 on electrical membrane properties of skeletal myotubes

(2010) Elisa Luin et al.   FREE RADICAL BIOLOGY AND MEDICINE

Biomarkers in Chronic Fatigue Syndrome: Evaluation of Natural Killer Cell Function and Dipeptidyl Peptidase IV/CD26

(2010) Mary A. Fletcher et al.   PLoS One

On the origin of serum CD26 and its altered concentration in cancer patients

(2009) Oscar J. Cordero et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Chronic fatigue syndrome combines increased exercise-induced oxidative stress and reduced cytokine and Hsp responses

(2009) Y. Jammes et al.   JOURNAL OF INTERNAL MEDICINE